Bioray Biotech Co (ROCO:7561) Scaled Net Operating Assets : 0.68 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Bioray Biotech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bioray Biotech Co's operating assets for the quarter that ended in Jun. 2024 was NT$409.5 Mil. Bioray Biotech Co's operating liabilities for the quarter that ended in Jun. 2024 was NT$42.3 Mil. Bioray Biotech Co's Total Assets for the quarter that ended in Dec. 2023 was NT$542.6 Mil. Therefore, Bioray Biotech Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.68.

Bioray Biotech Co Scaled Net Operating Assets Historical Data

The historical data trend for Bioray Biotech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioray Biotech Co Scaled Net Operating Assets Chart

Bioray Biotech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.50

0.58

0.61

0.89

0.68

Bioray Biotech Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial								0.77	0.91	0.70	0.72	0.68

Competitive Comparison of Bioray Biotech Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Bioray Biotech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioray Biotech Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioray Biotech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Bioray Biotech Co's Scaled Net Operating Assets falls into.

Save

Bioray Biotech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bioray Biotech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(445.624	-	38.96)	/	598.629
=	0.68

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	542.648	-	97.024
=	445.624

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	108.752	-	65.655	-	4.137
=	38.96

Bioray Biotech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(409.516	-	42.339)	/	542.648
=	0.68

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	550.062	-	140.546
=	409.516

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	133.097	-	46.069	-	44.689
=	42.339

Bioray Biotech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Bioray Biotech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioray Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846

Website

https://www.bio-ray.com.tw

Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.

Bioray Biotech Co Headlines

No Headlines